Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep 11:6:2324709618800108.
doi: 10.1177/2324709618800108. eCollection 2018 Jan-Dec.

Left Atrial Appendage Occlusion Complicated by Appendage Perforation Rescued by Device Deployment

Affiliations

Left Atrial Appendage Occlusion Complicated by Appendage Perforation Rescued by Device Deployment

Anna Sarcon et al. J Investig Med High Impact Case Rep. .

Abstract

The Watchman device is a transcatheter left atrial appendage (LAA) occluding device used in patients with nonvalvular atrial fibrillation (NVAF) and a high CHADS2-VA2SC score who are poor long-term anticoagulation candidates. Pericardial effusion related to device deployment and perforation can be a life-threatening complication. While not common in hands of experienced operators, management may require surgical intervention. Here we present a rare case of LAA perforation, which was corrected by successful repositioning of the device foregoing the need for surgical management.

Keywords: Watchman; left atrial appendage occlusion; pericardial effusion.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Transesophageal echocardiography images showing the Watchman device located in the patient’s transverse sinus. (A) Crown of the Watchman device (blue arrow) can be seen in the transverse sinus beyond the wall of the left atrial appendage (LAA; red arrow). (B) The sheath (yellow arrow) was not in the plane of view in image “A” but can be seen passing through the LAA into the transverse sinus in image “B.” The Watchman device (blue arrow) remains connected to the delivery system. Transverse sinus is showing evidence of fluid accumulation relative to preprocedure images (not shown).
Figure 2.
Figure 2.
Transesophageal echocardiography images with color Doppler 2 days after device placement shows Watchman deep in the left atrial appendage, without significant peri-device leak. Fluid is no longer apparent in the transverse sinus.
Figure 3.
Figure 3.
Computed tomography chest 1-month postprocedure showing adequate device positioning (blue arrow) with a small residual pericardial effusion (red arrow).

Similar articles

Cited by

References

    1. Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996;61:755-759. - PubMed
    1. Fountain RB, Holmes DR, Chandrasekaran K, et al. The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) trial. Am Heart J. 2006;151:956-961. - PubMed
    1. Reddy VY, Gibson DN, Kar S, et al. Post-approval US experience with left atrial appendage closure for stroke prevention in atrial fibrillation. J Am Coll Cardiol. 2017;69:253-261. - PubMed
    1. Boersma LVA, Schmidt B, Betts TR, et al. ; EWOLUTION investigators. Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry. Eur Heart J. 2016;37:2465-2474. - PMC - PubMed
    1. Möbius-Winkler S, Majunke N, Sandri M, et al. Percutaneous left atrial appendage closure: technical aspects and prevention of periprocedural complications with the Watchman device. World J Cardiol. 2015;7:65-75. - PMC - PubMed

LinkOut - more resources